Molecular Profiling of BRAF-V600E-Mutant Metastatic Colorectal Cancer in the Phase 3 BEACON CRC Trial

In this exploratory biomarker analysis of the BEACON CRC study, researchers characterized genomic and transcriptomic correlates of clinical outcomes and acquired resistance mechanisms through integrated clinical and molecular analysis.